Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:NVDA NYSE:NVO NASDAQ:RENT NASDAQ:SCWO NASDAQ:SKYE NASDAQ:SPWR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNVDANVIDIA$181.51-0.1%$168.81$86.62▼$184.48$4.43T2.14238.50 million shs181.57 million shsNVONovo Nordisk A/S$56.49+2.1%$61.78$45.05▼$139.74$252.21B0.6311.78 million shs11.49 million shsRENTRent the Runway$5.62+3.5%$4.93$3.69▼$15.41$22.37M1.3892,405 shs50,964 shsSCWO374Water$0.30+11.0%$0.26$0.16▼$1.99$45.31M-0.291.03 million shs1.87 million shsSKYESkye Bioscience$3.46-3.4%$3.74$1.14▼$7.11$107.22M2.21653,802 shs90,535 shsSPWRCSLM Acquisition$1.51-5.0%$1.70$1.19▼$3.37$125.50M0.77747,401 shs521,942 shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNVDANVIDIA+1.09%+3.49%+4.77%+34.83%+43.74%NVONovo Nordisk A/S-1.89%+1.00%-22.86%-19.45%-59.14%RENTRent the Runway+5.44%+19.13%+4.83%-6.22%-57.34%SCWO374Water+5.71%+11.19%+4.32%-43.12%-74.51%SKYESkye Bioscience+1.13%+7.51%-8.44%+79.45%-47.81%SPWRCSLM Acquisition-1.24%-3.64%-8.62%-11.91%-17.19%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationNVDANVIDIA4.5441 of 5 stars2.54.01.73.03.22.51.9NVONovo Nordisk A/S4.637 of 5 stars4.15.02.50.02.50.03.1RENTRent the Runway2.7896 of 5 stars3.34.00.00.02.92.50.0SCWO374Water0.7996 of 5 stars0.03.00.00.01.73.30.0SKYESkye Bioscience1.6176 of 5 stars3.62.00.00.01.60.80.0SPWRCSLM Acquisition4.3664 of 5 stars3.30.00.04.42.94.20.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceNVDANVIDIA 2.93Moderate Buy$194.317.05% UpsideNVONovo Nordisk A/S 2.13Hold$81.0043.40% UpsideRENTRent the Runway 2.50Moderate Buy$33.00487.19% UpsideSCWO374Water 0.00N/AN/AN/ASKYESkye Bioscience 3.14Buy$15.50347.98% UpsideSPWRCSLM Acquisition 2.50Moderate Buy$6.00297.35% UpsideCurrent Analyst Ratings BreakdownLatest RENT, NVDA, SPWR, SCWO, NVO, and SKYE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/25/2025NVDANVIDIAStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$202.00 ➝ $212.008/25/2025NVDANVIDIARobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$195.00 ➝ $225.008/22/2025NVDANVIDIAEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$190.00 ➝ $214.008/22/2025NVONovo Nordisk A/SDbs BankSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong Sell ➝ Hold8/21/2025NVDANVIDIAWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$175.00 ➝ $210.008/21/2025NVDANVIDIAUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$175.00 ➝ $205.008/20/2025NVDANVIDIAKeyCorpSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$190.00 ➝ $215.008/20/2025NVONovo Nordisk A/SZacks ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeHold ➝ Strong Sell8/19/2025NVDANVIDIATD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$140.00 ➝ $235.008/19/2025NVONovo Nordisk A/STD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$105.00 ➝ $70.008/18/2025NVDANVIDIACitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight(Data available from 8/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookNVDANVIDIA$130.50B33.94$3.09 per share58.81$3.25 per share55.85NVONovo Nordisk A/S$42.12B5.99$3.91 per share14.44$5.73 per share9.86RENTRent the Runway$300.80M0.07$4.39 per share1.28($46.59) per share-0.12SCWO374Water$1.23M36.79N/AN/A$0.06 per share5.00SKYESkye BioscienceN/AN/AN/AN/A$1.41 per shareN/ASPWRCSLM Acquisition$244.47M0.51N/AN/A($1.29) per share-1.17Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateNVDANVIDIA$72.88B$3.1058.5545.611.5751.69%105.09%72.19%8/27/2025 (Estimated)NVONovo Nordisk A/S$14.64B$3.6415.5212.121.9635.60%78.64%24.51%11/5/2025 (Estimated)RENTRent the Runway-$69.90M-$19.13N/AN/AN/A-24.60%N/A-29.77%9/11/2025 (Estimated)SCWO374Water-$12.43M-$0.11N/A∞N/A-1,278.90%-138.71%-109.45%11/12/2025 (Estimated)SKYESkye Bioscience-$26.57M-$1.06N/AN/AN/AN/A-76.03%-69.20%N/ASPWRCSLM Acquisition-$56.45MN/A0.00N/AN/A-18.51%-0.35%0.27%N/ALatest RENT, NVDA, SPWR, SCWO, NVO, and SKYE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/27/2025Q2 2026NVDANVIDIA$1.00N/AN/AN/A$45.65 billionN/A8/13/2025Q2 2025SPWRCSLM Acquisition$0.01-$0.28-$0.29-$0.28$52.26 million$67.52 million8/12/2025Q2 2025SCWO374Water-$0.02-$0.03-$0.01-$0.03$5.20 million$0.60 million8/7/2025Q2 2025SKYESkye Bioscience-$0.34-$0.44-$0.10-$0.44N/AN/A8/6/2025Q2 2025 NVONovo Nordisk A/S$0.93$0.97+$0.04$0.91$77.51 billion$11.69 billion6/5/2025Q1 2026RENTRent the Runway-$7.43-$6.58+$0.85-$6.58$68.70 million$69.60 million5/28/2025Q1 2026NVDANVIDIA$0.87$0.81-$0.06$0.76$43.09 billion$44.06 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthNVDANVIDIA$0.040.02%N/A1.29%1 YearsNVONovo Nordisk A/S$0.821.45%N/A22.53%N/ARENTRent the RunwayN/AN/AN/AN/AN/ASCWO374WaterN/AN/AN/AN/AN/ASKYESkye BioscienceN/AN/AN/AN/AN/ASPWRCSLM AcquisitionN/AN/AN/AN/AN/ALatest RENT, NVDA, SPWR, SCWO, NVO, and SKYE DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date8/7/2025NVONovo Nordisk A/Ssemi-annual$0.41192.4%8/18/20258/18/20258/26/20255/28/2025NVDANVIDIAquarterly$0.010.03%6/11/20256/11/20257/3/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioNVDANVIDIA0.103.392.96NVONovo Nordisk A/S0.520.780.56RENTRent the RunwayN/A1.221.22SCWO374WaterN/A2.611.98SKYESkye BioscienceN/A6.096.09SPWRCSLM AcquisitionN/A1.151.10Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipNVDANVIDIA65.27%NVONovo Nordisk A/S11.54%RENTRent the Runway73.10%SCWO374Water12.16%SKYESkye Bioscience21.09%SPWRCSLM Acquisition47.36%Insider OwnershipCompanyInsider OwnershipNVDANVIDIA4.17%NVONovo Nordisk A/S0.07%RENTRent the Runway8.53%SCWO374Water20.30%SKYESkye Bioscience3.00%SPWRCSLM Acquisition44.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableNVDANVIDIA36,00024.40 billion23.38 billionOptionableNVONovo Nordisk A/S77,3494.47 billion4.46 billionOptionableRENTRent the Runway1,0533.98 million3.64 millionOptionableSCWO374Water20151.03 million120.37 millionNot OptionableSKYESkye Bioscience1130.99 million30.06 millionOptionableSPWRCSLM Acquisition15183.11 million46.04 millionNot OptionableRENT, NVDA, SPWR, SCWO, NVO, and SKYE HeadlinesRecent News About These CompaniesContrasting CSLM Acquisition (NASDAQ:SPWR) and Turbo Energy (NASDAQ:TURB)August 22, 2025 | americanbankingnews.comCSLM Acquisition (NASDAQ:SPWR) Issues Earnings ResultsAugust 17, 2025 | marketbeat.comCSLM Acquisition (NASDAQ:SPWR) Shares Down 5.7% - What's Next?August 3, 2025 | marketbeat.comSunPower To Attend Canaccord's Annual Growth Conference August 12th in BostonJuly 29, 2025 | globenewswire.comSPWR Q2'25: $67.5M Revenue, $2.4M Operating ProfitJuly 22, 2025 | globenewswire.comSunPower to Report 2Q'25 Results July 22, 2025July 17, 2025 | globenewswire.comCSLM Acquisition Corp. (SPWR) Stock Dips While Market Gains: Key FactsJuly 15, 2025 | msn.comCSLM Acquisition Corp. (SPWR) Stock Dips While Market Gains: Key FactsJuly 14, 2025 | zacks.comCSLM Acquisition Corp. (SPWR) Falls More Steeply Than Broader Market: What Investors Need to KnowJuly 8, 2025 | zacks.comSunPower Joins the Russell 3000 & Russell Microcap IndicesJune 30, 2025 | globenewswire.comCSLM Digital Asset Acquisition Files for IPOJune 18, 2025 | marketwatch.comHas CSLM Acquisition Corp. (SPWR) Outpaced Other Oils-Energy Stocks This Year?June 12, 2025 | zacks.comCEO T.J. Rodgers on Solar ITC Loss - The Globe and MailJune 10, 2025 | theglobeandmail.comCEO T.J. Rodgers on Solar ITC LossJune 9, 2025 | globenewswire.comThurman J. Rodgers Purchases 21,177 Shares of Complete Solaria, Inc. (NASDAQ:SPWR) StockJune 6, 2025 | insidertrades.comChairman and CEO TJ Rodgers buys 300,000 shares of Complete SolariaJune 5, 2025 | msn.comCEO Thanks Shareholders for Ongoing SupportMay 30, 2025 | globenewswire.comComplete Solaria Delays Q1 2025 Financial ReportMay 14, 2025 | tipranks.comWhy Complete Solaria, Inc.’s (SPWR) Stock Is Down 5.03%May 5, 2025 | aaii.comAComplete Solaria announces strategic vision updateApril 23, 2025 | uk.investing.comComplete Solaria announces rebrand as SunPowerApril 21, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesTrump GLP-1 Pilot Program Could Boost Novo Nordisk & Eli LillyBy Jordan Chussler | August 9, 2025Data Centers Create a Bull Case for These Nuclear 3 StocksBy Gabriel Osorio-Mazilli | August 14, 2025AMD Outperforming NVIDIA: What’s Behind It and Can It Continue?By Dan Schmidt | August 4, 2025The Case for Buying NVIDIA Stock Ahead of the Robotics SurgeBy Thomas Hughes | August 20, 20255 Stocks Insiders Are Selling That Analysts Say BuyBy Thomas Hughes | August 13, 2025RENT, NVDA, SPWR, SCWO, NVO, and SKYE Company DescriptionsNVIDIA NASDAQ:NVDA$181.51 -0.26 (-0.14%) Closing price 04:00 PM EasternExtended Trading$177.14 -4.38 (-2.41%) As of 04:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NVIDIA Corporation provides graphics and compute and networking solutions in the United States, Taiwan, China, Hong Kong, and internationally. The Graphics segment offers GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; virtual GPU or vGPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems; and Omniverse software for building and operating metaverse and 3D internet applications. The Compute & Networking segment comprises Data Center computing platforms and end-to-end networking platforms, including Quantum for InfiniBand and Spectrum for Ethernet; NVIDIA DRIVE automated-driving platform and automotive development agreements; Jetson robotics and other embedded platforms; NVIDIA AI Enterprise and other software; and DGX Cloud software and services. The company's products are used in gaming, professional visualization, data center, and automotive markets. It sells its products to original equipment manufacturers, original device manufacturers, system integrators and distributors, independent software vendors, cloud service providers, consumer internet companies, add-in board manufacturers, distributors, automotive manufacturers and tier-1 automotive suppliers, and other ecosystem participants. NVIDIA Corporation was incorporated in 1993 and is headquartered in Santa Clara, California.Novo Nordisk A/S NYSE:NVO$56.48 +1.15 (+2.07%) Closing price 03:59 PM EasternExtended Trading$56.17 -0.31 (-0.56%) As of 04:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.Rent the Runway NASDAQ:RENT$5.62 +0.19 (+3.50%) Closing price 04:00 PM EasternExtended Trading$5.64 +0.01 (+0.27%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Rent the Runway, Inc. operates shared designer closet in the United States. The company offers evening wear and accessories, ready-to-wear, workwear, denim, casual, maternity, outerwear, blouses, knitwear, loungewear, jewelry, handbags, activewear, and ski wear under subscription, rental, and resale offering. It also engages in the software development and support activities. Rent the Runway, Inc. was incorporated in 2009 and is headquartered in Brooklyn, New York.374Water NASDAQ:SCWO$0.30 +0.03 (+11.03%) Closing price 04:00 PM EasternExtended Trading$0.32 +0.02 (+6.33%) As of 04:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.374Water Inc. provides a technology that transforms wet wastes into recoverable resources in the United States. The company transforms wet wastes, including sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals. It offers AirSCWO systems, a waste stream treatment system based on supercritical water oxidation that are used to treat various hazardous and non-hazardous waste streams. It serves Industrial, agricultural, defense, oil and gas, waste management, sanitation project, environmental remediation and compliance, and municipal markets. 374Water Inc. is based in Durham, North Carolina.Skye Bioscience NASDAQ:SKYE$3.46 -0.12 (-3.35%) Closing price 04:00 PM EasternExtended Trading$3.53 +0.07 (+2.02%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Skye Bioscience, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. The company's lead product candidate is SBI-100 used in the treatment of glaucoma and ocular hypertension. It is also developing SBI-200 to treat and manage various eye diseases, including uveitis, dry eye syndrome, macular degeneration and diabetic retinopathy. It has license agreement with university of Mississippi. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. The company is headquartered in San Diego, California.CSLM Acquisition NASDAQ:SPWR$1.51 -0.08 (-5.03%) As of 04:00 PM EasternComplete Solaria, Inc. engages in the provision of solar services. It offers sales enablement, project management, partner coordination, and customer communication. The company is headquartered in San Ramon, CA and does business as SunPower Corporation. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Williams-Sonoma Q2 Results Prove Its Buy-and-Hold Quality Okta: Market Comes to a Boil, Explosive Upside Is Possible MongoDB Roars Back to Life: It’s Not Too Late to Buy More Vertical Aerospace: An Analyst's Roadmap to a Potential Re-Rating AEHR Spikes 36% on Hyperscaler Order—Investors Should Take Notice From Debt to Liftoff: EchoStar's $23 Billion Catalyst Buffett’s Wisdom Could Spell Trouble for Palantir Shorts Tesla Just Had Its Best Day in 2 Months—Here’s What It Means Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.